BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
63 hedge funds and large institutions have $42.1M invested in BioDelivery Sciences International, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 20 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
3% more capital invested
Capital invested by funds: $40.8M → $42.1M (+$1.29M)
18% less funds holding
Funds holding: 77 → 63 (-14)
22% less call options, than puts
Call options by funds: $134K | Put options by funds: $172K
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.35M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$700K |
| 3 |
HP
Hikari Power
Tokyo,
Japan
|
+$510K |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$482K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$471K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.48M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$1.13M |
| 3 |
RA
Royce & Associates
New York
|
-$965K |
| 4 |
EC
Engaged Capital
Newport Beach,
California
|
-$330K |
| 5 |
Morgan Stanley
New York
|
-$330K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFCA
76
R&F Capital Advisors
New York
| – | -$28K | -16,105 | Closed |
|
|
FCM
77
Flinton Capital Management
Philadelphia,
Pennsylvania
| – | -$25K | -14,096 | Closed |
|
|
AIM
78
Acrospire Investment Management
Chicago,
Illinois
| – | -$22K | -12,420 | Closed |
|
79
Balyasny Asset Management
Chicago,
Illinois
| – | -$18K | -10,300 | Closed |
|
80
EARNEST Partners
Atlanta,
Georgia
| – | -$5K | -2,800 | Closed |
|
|
AP
81
Atwood & Palmer
Kansas City,
Missouri
| – | -$4K | -2,000 | Closed |
|
82
US Bancorp
Minneapolis,
Minnesota
| – | -$579 | -300 | -60% |
|
BDSI Hedge Fund Activity: Q1 2017 in Review
63 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2017, worth a combined $42.1M — up 3.2% from $40.8M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BDSI and 11 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 20 added.
The largest buyer was BlackRock, opening a new position worth an estimated $2.35M. The largest seller was Ameriprise, cutting an estimated $1.48M.
- 63 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2017, down from 77 in Q4 2016.
- Funds reported $42.1M of BioDelivery Sciences International, Inc. stock for Q1 2017, up 3.2% quarter-over-quarter.
- 11 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2017 and 20 closed out, a net change of -9 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2017 was BlackRock, an estimated $2.35M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2017 was Ameriprise, an estimated $1.48M sold.
Based on aggregated 13F filings for Q1 2017.